Leijiao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leijiao Li has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
Wenliang Li
School o Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun, 130022, China
13 shared publicationsPing Gao
School of Chemistry and Environmental Engineering, Changchun University of Science and Technology
8 shared publicationsBao Wang
School of Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun 130022, P. R. China
7 shared publications- Wenliang Li
School of Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun, 130022, PR China
7 shared publications Xiangyang Li
Changchun University of Science and Technology, Changchun 130022, China
7 shared publicationsXincui Shi
School of Chemistry and Environmental Engineering, Changchun University of Science and Technology, Changchun, P. R. China
7 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by Wiley in Advanced Healthcare Materials
- p. e71951
A Biocatalytic Cascade‐Based Cu‐GMP Self‐Assembly Nanozyme for Accelerating Infected Diabetic Wound Healing
Nanozymes with multi‐enzyme catalytic properties have emerged as promising multifunctional materials for biosensing and antimicrobial applications. Herein, a copper‐guanosine monophosphate (Cu‐GMP) nanozyme was synthesized via a simple one‐pot method. Its supramolecular network serves as a multifunctional carrier, enabling the encapsulation of functional guest biomolecules and retaining their inherent activity simultaneously. As a proof‐of‐concept, glucose oxidase (GOx) was incorporated to construct a glucose‐responsive cascade catalytic system (GOx@Cu‐GMP). In this system, GOx catalyzes glucose oxidation to produce hydrogen peroxide (H 2 O 2 ) and gluconic acid. The latter creates a localized acidic microenvironment, which combined with in situ generated H 2 O 2 , effectively activates the peroxidase (POD)‐like activity of Cu‐GMP and further generates hydroxyl radicals (•OH). Leveraging this cascade reaction, GOx@Cu‐GMP was developed as a sensitive colorimetric platform for glucose detection. Furthermore, Cu‐GMP exhibits oxidase (OXD)‐, laccase (LAC)‐, and glutathione peroxidase (GPx)‐like activities, facilitating the generation of various reactive oxygen species. Benefiting from multi‑enzyme synergy, it achieves broad‑spectrum antibacterial performance. Moreover, GOx@Cu‐GMP can eliminate bacterial infections and accelerate wound healing in a diabetic mouse skin wound model. This work provides a multifunctional nanozyme‐based platform for glucose detection and diabetic wound antimicrobial therapy, offering new insights for the development of integrated biosensing and therapeutic materials.
- 5 November 2026
- Published by Wiley in Advanced Healthcare Materials
- p. e71951
Open AccessA Biocatalytic Cascade‐Based Cu‐GMP Self‐Assembly Nanozyme for Accelerating Infected Diabetic Wound Healing
Nanozymes with multi‐enzyme catalytic properties have emerged as promising multifunctional materials for biosensing and antimicrobial applications. Herein, a copper‐guanosine monophosphate (Cu‐GMP) nanozyme was synthesized via a simple one‐pot method. Its supramolecular network serves as a multifunctional carrier, enabling the encapsulation of functional guest biomolecules and retaining their inherent activity simultaneously. As a proof‐of‐concept, glucose oxidase (GOx) was incorporated to construct a glucose‐responsive cascade catalytic system (GOx@Cu‐GMP). In this system, GOx catalyzes glucose oxidation to produce hydrogen peroxide (H 2 O 2 ) and gluconic acid. The latter creates a localized acidic microenvironment, which combined with in situ generated H 2 O 2 , effectively activates the peroxidase (POD)‐like activity of Cu‐GMP and further generates hydroxyl radicals (•OH). Leveraging this cascade reaction, GOx@Cu‐GMP was developed as a sensitive colorimetric platform for glucose detection. Furthermore, Cu‐GMP exhibits oxidase (OXD)‐, laccase (LAC)‐, and glutathione peroxidase (GPx)‐like activities, facilitating the generation of various reactive oxygen species. Benefiting from multi‑enzyme synergy, it achieves broad‑spectrum antibacterial performance. Moreover, GOx@Cu‐GMP can eliminate bacterial infections and accelerate wound healing in a diabetic mouse skin wound model. This work provides a multifunctional nanozyme‐based platform for glucose detection and diabetic wound antimicrobial therapy, offering new insights for the development of integrated biosensing and therapeutic materials.
- Open Access
- 28 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1794356
Advances in platinum-based drug development for cervical cancer therapy
Cervical cancer remains a predominant malignancy of the female reproductive system and a critical global health challenge. Traditional platinum-based agents such as cisplatin, carboplatin, and oxaliplatin, are cornerstones in postoperative adjuvant therapy, management of locally advanced cases, and systemic treatment of recurrent/metastatic disease. However, their clinical efficacy is frequently hampered by severe systemic toxicities and the emergence of chemoresistance. To address these bottlenecks, diverse nano-delivery platforms have been engineered to enhance bioavailability and mitigate adverse effects. This review systematically delineates the evolution of first-to third-generation platinum drugs, elucidating their molecular mechanisms of action specifically within the landscape of cervical cancer. Furthermore, we critically evaluate the clinical application of these agents and provide a comprehensive synthesis of recent advances in nano-delivery systems, including targeted and stimuli-responsive carriers. By bridging traditional pharmacology with cutting-edge nanotechnology, this review offers strategic insights into achieving precise delivery and controlled release, potentially defining new paradigms for the next-generation of cervical cancer therapeutics.
- 28 October 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1794356
Open AccessAdvances in platinum-based drug development for cervical cancer therapy
Cervical cancer remains a predominant malignancy of the female reproductive system and a critical global health challenge. Traditional platinum-based agents such as cisplatin, carboplatin, and oxaliplatin, are cornerstones in postoperative adjuvant therapy, management of locally advanced cases, and systemic treatment of recurrent/metastatic disease. However, their clinical efficacy is frequently hampered by severe systemic toxicities and the emergence of chemoresistance. To address these bottlenecks, diverse nano-delivery platforms have been engineered to enhance bioavailability and mitigate adverse effects. This review systematically delineates the evolution of first-to third-generation platinum drugs, elucidating their molecular mechanisms of action specifically within the landscape of cervical cancer. Furthermore, we critically evaluate the clinical application of these agents and provide a comprehensive synthesis of recent advances in nano-delivery systems, including targeted and stimuli-responsive carriers. By bridging traditional pharmacology with cutting-edge nanotechnology, this review offers strategic insights into achieving precise delivery and controlled release, potentially defining new paradigms for the next-generation of cervical cancer therapeutics.
- Open Access
- 1 July 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 61, 229-242
NIR-II aggregation-induced emission sonosensitizer for pyroptosis induction in bladder cancer
Sonodynamic therapy (SDT) represents a promising methodology that employs sonosensitizers in conjunction with low-intensity ultrasound for the eradication of malignant tumors, featuring precise treatment capabilities, deep tissue penetrability, and minimal side effects. Conventional sonosensitizers often face challenges such as aggregation-caused quenching (ACQ), which hampers the efficiency of reactive oxygen species (ROS) generation. In this study, we report a novel benzothiadiazole-based sonosensitizer derivative, BBTPA, exhibiting aggregation-induced emission (AIE) characteristics. By co-assembling BBTPA with the ROS-responsive polymer PMD and the amphiphilic polymer DSPE-PEG2000, we engineered BBTPA nanoparticles (NPBBTPA). Upon ultrasound exposure, NPBBTPA produces ROS efficiently, inducing mitochondrial damage and triggering pyroptotic cell death. Moreover, NPBBTPA induces immunogenic cell death (ICD) under ultrasound stimulation, thus enhancing antitumor immune responses. This study extends the utility of AIE-based sonodynamic agents in efficient cancer therapy, holding promising prospects for bladder cancer treatment.
- 1 July 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 61, 229-242
Open AccessNIR-II aggregation-induced emission sonosensitizer for pyroptosis induction in bladder cancer
Sonodynamic therapy (SDT) represents a promising methodology that employs sonosensitizers in conjunction with low-intensity ultrasound for the eradication of malignant tumors, featuring precise treatment capabilities, deep tissue penetrability, and minimal side effects. Conventional sonosensitizers often face challenges such as aggregation-caused quenching (ACQ), which hampers the efficiency of reactive oxygen species (ROS) generation. In this study, we report a novel benzothiadiazole-based sonosensitizer derivative, BBTPA, exhibiting aggregation-induced emission (AIE) characteristics. By co-assembling BBTPA with the ROS-responsive polymer PMD and the amphiphilic polymer DSPE-PEG2000, we engineered BBTPA nanoparticles (NPBBTPA). Upon ultrasound exposure, NPBBTPA produces ROS efficiently, inducing mitochondrial damage and triggering pyroptotic cell death. Moreover, NPBBTPA induces immunogenic cell death (ICD) under ultrasound stimulation, thus enhancing antitumor immune responses. This study extends the utility of AIE-based sonodynamic agents in efficient cancer therapy, holding promising prospects for bladder cancer treatment.
- 29 April 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (41) , 10441-10445
Size-tunable hemoglobin oxygen carriers with antioxidant and pro-angiogenic functions for wound healing
CA-functionalized Hb-Oxy with tunable sizes are synthesized via a template-assisted strategy. These carriers exhibit optimized oxygen affinity and antioxidant activity, accelerating wound healing by alleviating hypoxia and suppressing inflammation.
- 29 April 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (41) , 10441-10445
Size-tunable hemoglobin oxygen carriers with antioxidant and pro-angiogenic functions for wound healing
CA-functionalized Hb-Oxy with tunable sizes are synthesized via a template-assisted strategy. These carriers exhibit optimized oxygen affinity and antioxidant activity, accelerating wound healing by alleviating hypoxia and suppressing inflammation.
- 20 March 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (9) , 2353-2360
A biodegradable polymeric nanoparticle vaccine for combating Acinetobacter baumannii infection
The developed NP-VAC is safe and highly immunogenic, providing full protection against A. baumannii and a strategy against bacterial infections.
- 20 March 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (9) , 2353-2360
A biodegradable polymeric nanoparticle vaccine for combating Acinetobacter baumannii infection
The developed NP-VAC is safe and highly immunogenic, providing full protection against A. baumannii and a strategy against bacterial infections.
- Open Access
- 13 February 2026
- Published by Elsevier in SSRN Electronic Journal
Interfacial Electronic Coupling in a 2D/2D CuCo-BDC/Mo2C Heterostructure for Enhanced Alkaline Oxygen Evolution
Developing efficient, stable, and non-precious metal oxygen evolution reaction (OER) electrocatalysts is of crucial importance for promoting the development of sustainable energy technologies. In this study, a two-dimensional/two-dimensional (2D/2D) heterostructured electrocatalyst was designed and synthesized by in-situ growth of bimetallic CuCo-BDC on Mo2CTx MXene (CuCo-BDC/Mo2C). The obtained CuCo-BDC/Mo2C catalyst exhibited excellent OER performance in 1.0 M KOH, requiring only 271 mV overpotential to drive 10 mA cm-2, featuring a Tafel slope as low as 73.8 mV dec-1, along with good long-term stability. The strong electronegativity of MXene triggers the interface electron transfer from MOF to MXene, optimizing the electronic structure of the Co active center. The heterostructure effectively prevents the stacking of nanosheets and regulates the redistribution of interface charges, thereby optimizing the adsorption of reaction intermediates. Moreover, catalytic post-analytical results confirms that the catalyst undergoes in situ electrochemical reconstruction during the OER process, transforming from crystalline MOF to amorphous metal (oxygen) hydroxide, which becomes the true active phase. This study emphasizes the strategy of combining a heterogeneous structure design with electrochemical driven surface reconstruction, which holds significant value in the development of highly efficient and stable OER electrocatalysts.
- 13 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessInterfacial Electronic Coupling in a 2D/2D CuCo-BDC/Mo2C Heterostructure for Enhanced Alkaline Oxygen Evolution
Developing efficient, stable, and non-precious metal oxygen evolution reaction (OER) electrocatalysts is of crucial importance for promoting the development of sustainable energy technologies. In this study, a two-dimensional/two-dimensional (2D/2D) heterostructured electrocatalyst was designed and synthesized by in-situ growth of bimetallic CuCo-BDC on Mo2CTx MXene (CuCo-BDC/Mo2C). The obtained CuCo-BDC/Mo2C catalyst exhibited excellent OER performance in 1.0 M KOH, requiring only 271 mV overpotential to drive 10 mA cm-2, featuring a Tafel slope as low as 73.8 mV dec-1, along with good long-term stability. The strong electronegativity of MXene triggers the interface electron transfer from MOF to MXene, optimizing the electronic structure of the Co active center. The heterostructure effectively prevents the stacking of nanosheets and regulates the redistribution of interface charges, thereby optimizing the adsorption of reaction intermediates. Moreover, catalytic post-analytical results confirms that the catalyst undergoes in situ electrochemical reconstruction during the OER process, transforming from crystalline MOF to amorphous metal (oxygen) hydroxide, which becomes the true active phase. This study emphasizes the strategy of combining a heterogeneous structure design with electrochemical driven surface reconstruction, which holds significant value in the development of highly efficient and stable OER electrocatalysts.
- Open Access
- 4 February 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Cascade catalytic nanozyme platform for combined antibacterial, anti-inflammatory, and pro-healing therapy of infected diabetic wounds
The wounds of diabetic patients are prone to bacterial infection due to complex microenvironments. Improving the microenvironment of diabetic wounds and co
- 4 February 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessCascade catalytic nanozyme platform for combined antibacterial, anti-inflammatory, and pro-healing therapy of infected diabetic wounds
The wounds of diabetic patients are prone to bacterial infection due to complex microenvironments. Improving the microenvironment of diabetic wounds and co
- 11 November 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (47) , 64967-64979
A Self-Oxygenating Nanozyme Cascade System for Drug-Resistant Bacterial Infected Diabetic Wound Healing
Chronic diabetic wounds remain challenging due to biofilm-associated antibiotic resistance, persistent hypoxia, and dysregulated inflammation. Here, we develop a copper-doped iron oxide nanozyme (CFO@PEG NPs) that synergizes with H2O2 to establish a trienzyme catalytic cascade for diabetic wound regeneration. The material exhibits peroxidase-, glutathione peroxidase-, and catalase-like activities, enabling continuous ROS generation, antioxidant depletion, and hypoxia alleviation. Physicochemical characterization confirms cubic CuFe2O4 nanostructures (200 nm) with coexisting Cu2+/Cu+ and Fe3+/Fe2+ redox pairs, which enhance charge transfer kinetics and multienzyme synergism. In vitro, CFO@PEG NPs (75 μg/mL) eradicate 99.9% of methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Escherichia coli (MREA) while clearing 90% of biofilms. In vivo, the system accelerates healing of MRSA-infected diabetic wounds through three interconnected mechanisms: (1) ROS-mediated bacterial membrane disruption, (2) catalase-driven O2 generation that reduces HIF-1α expression and increases CD31 neovessels, and (3) immunomodulation shifting macrophages from pro-inflammatory M1 (TNF-α: 8.5 vs 90.1 pg/mL) to reparative M2 phenotypes (IL-10:103.7 vs 21.8 pg/mL). Full wound closure is achieved within 8 days without systemic toxicity. This work provides a paradigm for engineering nanozyme cascades to address the multidimensional challenges in chronic infected wound therapy.
- 11 November 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (47) , 64967-64979
A Self-Oxygenating Nanozyme Cascade System for Drug-Resistant Bacterial Infected Diabetic Wound Healing
Chronic diabetic wounds remain challenging due to biofilm-associated antibiotic resistance, persistent hypoxia, and dysregulated inflammation. Here, we develop a copper-doped iron oxide nanozyme (CFO@PEG NPs) that synergizes with H2O2 to establish a trienzyme catalytic cascade for diabetic wound regeneration. The material exhibits peroxidase-, glutathione peroxidase-, and catalase-like activities, enabling continuous ROS generation, antioxidant depletion, and hypoxia alleviation. Physicochemical characterization confirms cubic CuFe2O4 nanostructures (200 nm) with coexisting Cu2+/Cu+ and Fe3+/Fe2+ redox pairs, which enhance charge transfer kinetics and multienzyme synergism. In vitro, CFO@PEG NPs (75 μg/mL) eradicate 99.9% of methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Escherichia coli (MREA) while clearing 90% of biofilms. In vivo, the system accelerates healing of MRSA-infected diabetic wounds through three interconnected mechanisms: (1) ROS-mediated bacterial membrane disruption, (2) catalase-driven O2 generation that reduces HIF-1α expression and increases CD31 neovessels, and (3) immunomodulation shifting macrophages from pro-inflammatory M1 (TNF-α: 8.5 vs 90.1 pg/mL) to reparative M2 phenotypes (IL-10:103.7 vs 21.8 pg/mL). Full wound closure is achieved within 8 days without systemic toxicity. This work provides a paradigm for engineering nanozyme cascades to address the multidimensional challenges in chronic infected wound therapy.
- 14 April 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (17) , 5181-5189
Metallized hollow-COF nanobowls with dual-mode ROS generation for cancer sonodynamic therapy
Sonodynamic therapy (SDT) has emerged as an encouraging route in tumor treatment, due to its exceptional tissue penetration depth and favorable safety profile. Nevertheless, the clinical translation of conventional organic sonosensitizers is hindered by intrinsic limitations, including pronounced hydrophobicity, insufficient chemical stability, and low reactive oxygen species (ROS) production. In contrast, hollow covalent organic frameworks (HCOFs) exhibit exceptional cargo-loading capabilities, structural robustness, and biocompatibility, positioning them as ideal nanoplatforms for advanced therapeutic applications. Herein, we engineered a bowl-shaped HCOF architecture designed to amplify ultrasonic cavitation effects. This nanostructure was subsequently functionalized with the sonosensitizer (Hemin) and subjected to strategic metallization via metal ion incorporation, culminating in the development of a high-efficiency antitumor nanosystem (FeHHCA). FeHHCA can achieve dual-mode ROS generation, namely, sonodynamic synergistically generating 1O2 and being specifically activated by a tumor microenvironment (TME) to generate ˙OH through a Fenton-like reaction, achieving an 78.7% tumor inhibition rate in vivo. These findings offer innovative approaches and strategies for the design of hollow COFs and offer great potential for the application of SDT in cancer treatment.
- 14 April 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (17) , 5181-5189
Metallized hollow-COF nanobowls with dual-mode ROS generation for cancer sonodynamic therapy
Sonodynamic therapy (SDT) has emerged as an encouraging route in tumor treatment, due to its exceptional tissue penetration depth and favorable safety profile. Nevertheless, the clinical translation of conventional organic sonosensitizers is hindered by intrinsic limitations, including pronounced hydrophobicity, insufficient chemical stability, and low reactive oxygen species (ROS) production. In contrast, hollow covalent organic frameworks (HCOFs) exhibit exceptional cargo-loading capabilities, structural robustness, and biocompatibility, positioning them as ideal nanoplatforms for advanced therapeutic applications. Herein, we engineered a bowl-shaped HCOF architecture designed to amplify ultrasonic cavitation effects. This nanostructure was subsequently functionalized with the sonosensitizer (Hemin) and subjected to strategic metallization via metal ion incorporation, culminating in the development of a high-efficiency antitumor nanosystem (FeHHCA). FeHHCA can achieve dual-mode ROS generation, namely, sonodynamic synergistically generating 1O2 and being specifically activated by a tumor microenvironment (TME) to generate ˙OH through a Fenton-like reaction, achieving an 78.7% tumor inhibition rate in vivo. These findings offer innovative approaches and strategies for the design of hollow COFs and offer great potential for the application of SDT in cancer treatment.